Skip to main content
. 2022 Jan 7;11(2):304. doi: 10.3390/jcm11020304

Figure 2.

Figure 2

Change in the visual analogue scale (VAS). VAS was evaluated for 60 weeks after the injection of the releasate isolated from activated platelet-rich plasma (PRPr) or corticosteroid (CS). The number in parentheses indicates weeks after the optional injection. Data were expressed as means ± standard error of the means (SEMs).